Results 21 to 30 of about 724,217 (261)
Journal of Pharmacoeconomics and Pharmaceutical Management, 2023 Background Hypertension is a chronic disease that cannot be cured and can only be controlled but requires long-term treatment, even for life. The variety of antihypertensive treatments makes it necessary to adjust the choice of treatment not only in ...
Ida Adhayanti +2 more
doaj +1 more source
Cost-effectiveness analysis in oncology
Annals of Oncology, 1998 Physicians are faced with a burgeoning literature of economic studies. However, most physicians have little training in evaluating economic research. Economic studies involve a comparison of the costs and benefits of alternative treatment options. To be of use for medical decision making, they should meet appropriate methodological standards.
C C, Earle, D, Coyle, W K, Evans
openaire +2 more sources
Cost–Effectiveness Analysis in Pharmacogenomics [PDF]
Pharmacogenomics, 2010 The existence of finite healthcare budgets drives the need to consider opportunity cost and demonstrate that pharmacogenomic interventions offer added value, in terms of the relative costs and benefits, compared with current practice. This is where the framework of cost-effectiveness analysis is useful.
Katherine, Payne, Fatiha H, Shabaruddin
openaire +2 more sources
QALY league table of Iran: a practical method for better resource allocation
Cost Effectiveness and Resource Allocation, 2021 Background The limited health care resources cannot meet all the demands of the society. Thus, decision makers have to choose feasible interventions and reject the others. We aimed to collect and summarize the results of all cost utility analysis studies
Reza Hashempour +4 more
doaj +1 more source
Global bibliometric analysis of cost effectiveness analysis in healthcare research from 2013 to 2023
Cost Effectiveness and Resource AllocationBackground Cost-effectiveness analysis (CEA) has become a crucial technique in appraising the efficiency of healthcare interventions and resource allocation decisions.
Kemdi Lugard Okoroiwu +4 more
doaj +1 more source
Nordic Journal of Health Economics, 2017 This paper compares the implementation of the two economic evaluation methods Cost-Effectiveness/Utility (CEA/CUA) and Cost-Benefit Analysis (CBA) as tools for allocation of national public funds in the health and transport sector in Sweden, respectively.
Mikael Svensson, Lars Hultkrantz
doaj +1 more source
Cambridge Prisms: Global Mental Health, 2022 Background Integrating services for depression into primary care is key to reducing the treatment gap in low- and middle-income countries. We examined the value of providing the Healthy Activity Programme (HAP), a behavioral activation psychological ...
L. R. Aldridge +4 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Pediatric bone sarcoma patients and survivors may experience psychosocial challenges related to childhood cancer after their intensive, body‐altering treatment. This cross‐sectional study aimed to evaluate generic and survivor‐specific psychosocial outcomes in a national cohort of pediatric bone sarcoma patients and survivors, and ...
Hinke van der Hoek +14 more
wiley +1 more source
A parsimonious model to validate cost-effectiveness analyses on preventive health care
BMC Health Services Research, 2021 Background The effect of preventive health care on health expenditures is ambiguous. On the one hand, prevention reduces the costs of future morbidity. On the other hand, prevention leads to costs of life extension.
Afschin Gandjour
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Adolescents with haematological malignancies face significant emotional and relational challenges, often accompanied by difficulties in communicating their needs within the healthcare context. To address these issues, a narrative‐based psycho‐educational intervention based on the creation and prescription of Ironic Medications was ...
Marta Stoppa +7 more
wiley +1 more source